Fennec Pharmaceuticals Inc (FENC) support and resistance · rev $44.6M
Fennec Pharmaceuticals Inc (FENC) is a biotechnology company listed on US.
This page maps Fennec Pharmaceuticals Inc (FENC) support and resistance from cached range and valuation — not a live tape and not a trade alert.
Latest reported FENC revenue for 2025-12-31 was $44.6M. Net income was -$9.7M. Revenue was down 6.1% from 2024-12-31 to 2025-12-31. FENC currently screens at market cap $302.2M.
FENC currently screens at market cap $302.2M. Round numbers near that cap and multiple often act as psychological resistance; prior-period revenue is the fundamental floor traders argue about.
A new FENC 8-K or 10-Q can move the levels that matter more than a drawing on a chart.
Not investment advice. Use the FENC quote page for the session range and the stock page for the full model.
Not investment advice.